Mytrex Health Technologies, Inc. (TPEX:4431)

TPEX:4431 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	300.63	275.02	218.66	486.53	471.21
Short-Term Investments	121	2.5	22.09	-	-
Cash & Short-Term Investments	421.63	277.52	240.75	486.53	471.21
Cash Growth	51.92%	15.28%	-50.52%	3.25%	-37.57%
Accounts Receivable	133.94	139.14	164.67	110.21	54.91
Other Receivables	25.84	52.19	41.18	53.43	-
Receivables	159.78	191.33	205.85	163.64	54.91
Inventory	210.85	200.96	203.22	184.58	54.9
Other Current Assets	21.71	21.82	22.11	22.67	19.06
Total Current Assets	813.96	691.64	671.93	857.42	600.08
Property, Plant & Equipment	81.98	129.04	241.14	285.37	253.19
Long-Term Investments	114.15	111.06	101.28	102.35	61.42
Goodwill	12.99	12.99	12.99	12.99	-
Other Intangible Assets	68.97	70.82	71.61	76.1	1.16
Long-Term Accounts Receivable	-	8.51	8.66	-	-
Long-Term Deferred Tax Assets	2.13	6.09	4.89	3.32	4.52
Other Long-Term Assets	89.21	115.54	145.7	150.51	33.74
Total Assets	1,183	1,146	1,258	1,488	954.12

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	340.67	208.37	228.4	204.44	5.74
Accrued Expenses	33.97	32.47	38.43	50.88	30.14
Short-Term Debt	57.57	61.09	57.47	13.25	-
Current Portion of Long-Term Debt	-	4.45	1.99	-	-
Current Portion of Leases	38.4	45.99	70.52	51.08	10.89
Current Income Taxes Payable	0.48	-	0.82	5.19	8.01
Current Unearned Revenue	1.77	1.28	2.61	1.55	0.96
Other Current Liabilities	40.85	51.51	41.52	31.03	19.2
Total Current Liabilities	513.71	405.15	441.75	357.42	74.94
Long-Term Debt	-	1.69	4.31	-	-
Long-Term Leases	67.1	111.22	116.39	144.5	43.61
Long-Term Deferred Tax Liabilities	10.41	10.62	11	11.43	-
Other Long-Term Liabilities	7.25	7.69	7.27	7.01	-
Total Liabilities	598.47	536.37	580.72	520.36	118.55

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	365.36	365.36	365.36	365.36	365.36
Additional Paid-In Capital	239.06	291.46	291.46	288.25	288.25
Retained Earnings	-16.17	-52.4	32.97	89.12	179.94
Comprehensive Income & Other	-3.33	-4.24	-14.94	-12.94	0.16
Total Common Equity	584.91	600.17	674.84	729.79	833.71
Minority Interest	-	9.13	2.63	237.9	1.86
Shareholders' Equity	584.91	609.31	677.47	967.7	835.57
Total Liabilities & Equity	1,183	1,146	1,258	1,488	954.12

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	163.07	224.44	250.67	208.83	54.51
Net Cash (Debt)	258.56	53.09	-9.93	277.7	416.7
Net Cash Growth	387.05%	-	-	-33.36%	-30.00%
Net Cash Per Share	7.08	1.45	-0.27	7.60	11.41
Filing Date Shares Outstanding	36.54	36.54	36.54	36.54	36.54
Total Common Shares Outstanding	36.54	36.54	36.54	36.54	36.54
Working Capital	300.25	286.49	230.18	500	525.14
Book Value Per Share	16.01	16.43	18.47	19.97	22.82
Tangible Book Value	502.96	516.37	590.25	640.71	832.55
Tangible Book Value Per Share	13.77	14.13	16.16	17.54	22.79
Land	-	-	13.9	13.9	-
Buildings	-	-	15.15	15.15	-
Machinery	403.23	400	395.33	393.57	370.97
Construction In Progress	-	-	-	11.61	-
Leasehold Improvements	64.73	67.32	82.88	72.41	47.61

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 28, 2026

Data Sources Report a data error